XLO (XLO) Stock Price & Analysis
XLO (XLO) rose 0.00% to USD 8.65 as of July 25, 2026 at 03:49 UTC, according to Nexqual real-time market data.
XLO last closed at USD 8.65; the session ranged USD 8.33–8.65 on volume of 16,933 shares. Market capitalization is —, with a 52-week range of USD 6.47–12.74 (NCM). Source: Nexqual, July 25, 2026 at 03:49 UTC.
Key Statistics (as of July 25, 2026 at 03:49 UTC)
| Price | USD 8.65 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 8.65 |
| Open | USD 8.65 |
| Day Range | USD 8.33 – 8.65 |
| 52-Week Range | USD 6.47 – 12.74 |
| Volume | 16,933 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (XLO)
Nexqual's technical model rates XLO "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 03:49 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 50.31 (neutral) |
| vs SMA50 | Above (USD 8.62) |
| MACD | -0.03 (negative) |
From XLO's Latest SEC 10-K Filing (filed 2026-03-23)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RLYB | Rallybio Corporation | USD 16.31 | ▼ 1.87% |
| HOWL | Werewolf Therapeutics, Inc. | USD 0.43 | ▲ 16.99% |
| TYRA | Tyra Biosciences, Inc. | USD 30.63 | ▲ 0.13% |
| INAB | IN8bio, Inc. | USD 1.2 | ▼ 2.44% |
| IMRX | Immuneering Corporation | USD 4.32 | ▼ 3.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:49 UTC. This page is informational and not investment advice.